Table 1.
Clinical descriptive statistics (N=262 patients).
| Median | Range | |
|---|---|---|
| Age at Diagnosis (years) | 58.8 | 39.6–72.4 |
| Pre-Biopsy PSA (ng/mL) | 4.9 | 0.8–35.9 |
| Clinical Stage | Number | % |
| T1c | 155 | 59.16 |
| T2 unspecified | 6 | 2.29 |
| T2a | 32 | 12.21 |
| T2b | 16 | 6.11 |
| T2c | 35 | 13.36 |
| T3a | 15 | 5.73 |
| T3b | 1 | 0.38 |
| T4 | 2 | 0.76 |
| Biopsy Gleason Score | Number | % |
| 3+3 | 178 | 67.94 |
| 3+4 | 49 | 18.70 |
| 4+3 | 22 | 8.40 |
| 4+4 | 10 | 3.82 |
| 4+5 | 3 | 1.14 |
| Median | Range | |
| Number of Negative Cores (NNC) | 9.0 | 0.0–29.0 |
| Number of Positive Cores (NPC) | 2.0 | 1.0–14.0 |
| Percent of Cores Positive | 20.0 | 3.7–100.0 |